BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7601403)

  • 1. Treatment of patients with cirrhosis and refractory ascites using LeVeen shunt with titanium tip: comparison with therapeutic paracentesis.
    Ginès A; Planas R; Angeli P; Guarner C; Salerno F; Ginès P; Saló J; Rodriguez N; Domènech E; Soriano G
    Hepatology; 1995 Jul; 22(1):124-31. PubMed ID: 7601403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
    N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.
    Ginés P; Arroyo V; Quintero E; Planas R; Bory F; Cabrera J; Rimola A; Viver J; Camps J; Jiménez W
    Gastroenterology; 1987 Aug; 93(2):234-41. PubMed ID: 3297907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Titanium catheter tip for peritoneovenous shunts.
    Franco D; Labianca M; Smadja C; Fragoso J; Halabi S
    Artif Organs; 1988 Feb; 12(1):81-2. PubMed ID: 3355388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.
    Ginès P; Titó L; Arroyo V; Planas R; Panés J; Viver J; Torres M; Humbert P; Rimola A; Llach J
    Gastroenterology; 1988 Jun; 94(6):1493-502. PubMed ID: 3360270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diuretic-resistant ascites in cirrhosis. Mechanism and treatment.
    Arroyo V
    Acta Gastroenterol Belg; 1990; 53(2):249-55. PubMed ID: 2267904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites.
    Titó L; Ginès P; Arroyo V; Planas R; Panés J; Rimola A; Llach J; Humbert P; Badalamenti S; Jiménez W
    Gastroenterology; 1990 Jan; 98(1):146-51. PubMed ID: 2293573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study.
    Fassio E; Terg R; Landeira G; Abecasis R; Salemne M; Podesta A; Rodriguez P; Levi D; Kravetz D
    J Hepatol; 1992 Mar; 14(2-3):310-6. PubMed ID: 1380024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of refractory ascites by the LeVeen shunt. A multi-centre controlled trial (57 patients).
    Bories P; Garcia Compean D; Michel H; Bourel M; Capron JP; Gauthier A; Lafon J; Lévy VG; Pascal JP; Quinton A
    J Hepatol; 1986; 3(2):212-8. PubMed ID: 3540097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ectopic ascites secondary to the implantation of a LeVeen shunt].
    Giménez Roca A; Xiol X; Sánchez M; Sesé E; Casais L
    Rev Esp Enferm Dig; 1993 Jan; 83(1):45-6. PubMed ID: 8452703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.
    Salerno F; Merli M; Riggio O; Cazzaniga M; Valeriano V; Pozzi M; Nicolini A; Salvatori F
    Hepatology; 2004 Sep; 40(3):629-35. PubMed ID: 15349901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneovenous shunting of intractable ascites in patients with cirrhosis: improving results and predictive factors of failure.
    Hillaire S; Labianca M; Borgonovo G; Smadja C; Grange D; Franco D
    Surgery; 1993 Apr; 113(4):373-9. PubMed ID: 8456392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of refractory chylous ascites with peritoneovenous shunts.
    Huang Y; Gloviczki P; Duncan AA; Fleming MD; Driscoll DJ; Kalra M; Oderich GS; Bower TC
    J Vasc Surg Venous Lymphat Disord; 2017 Jul; 5(4):538-546. PubMed ID: 28623993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cure of recurrent ascites in alcoholic hepatitis following transient placement of a LeVeen shunt].
    Yersin B; Genton A; Mosimann R; Magnenat P
    Schweiz Med Wochenschr; 1989 May; 119(21):768-9. PubMed ID: 2756407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent ascites due to central venous thrombosis after peritoneojugular (LeVeen) shunt.
    Smadja C; Tridard D; Franco D
    Surgery; 1986 Sep; 100(3):535-41. PubMed ID: 3738774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peritoneovenous shunting in intractable ascites of cirrhosis. Results of a prospective study on improving prognostic factors].
    Hillaire S; Labianca M; Smadja C; Grange D; Franco D
    Gastroenterol Clin Biol; 1988 Oct; 12(10):681-6. PubMed ID: 3220223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study.
    Solà R; Vila MC; Andreu M; Oliver MI; Coll S; Gana J; Ledesma S; Ginès P; Jiménez W; Arroyo V
    J Hepatol; 1994 Feb; 20(2):282-8. PubMed ID: 7516361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Tan HK; James PD; Wong F
    Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.